Cybergenetics Awarded Contract To Identify World Trade Center Victim Remains Using TrueAllele(R) Technology; Advanced TrueAllele(R) SuperComputer To Help Identify WTC Victims

PITTSBURGH--(BUSINESS WIRE)--Sept. 8, 2006--Cybergenetics has been awarded a contract by New York City's Office of the Chief Medical Examiner (OCME) to apply its unique TrueAllele(R) technology for identifying World Trade Center (WTC) remains. Cybergenetics is the leading innovator of automated forensic DNA interpretation technology.